In the context of nuclear driver mutations, an upregulation of tumour mtDNA copy number has been significantly associated with IDH1 mutation in low‐grade gliomas and TP53 mutations in ovarian carcinoma. The gene discussed is IDH1; the disease is central nervous system cancer.